Diagnosis and Management of Hypertrophic Cardiomyopathy

1. Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy
2. Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy
3. Genetic Basis and Genotype–Phenotype Relationships in Familial Hypertrophic Cardiomyopathy
4. Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
5. Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management
6. Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
7. Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy
8. Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance
9. Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions
10. Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy
11. Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy
12. Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression
13. Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy
14. Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and Not So Benign Arrhythmias
15. The Athlete’s Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies
16. Importance of Congenital Coronary Artery Anomalies
17. Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program
18. Naturally Occurring Animal Models of Cardiovascular Disease Causing Premature Death
19. The Role of the Internet and Patient Support Groups for Those Living with Hypertrophic Cardiomyopathy

Diagnosis and Management of Hypertrophic Cardiomyopathy is a unique, multi-authored compendium of information regarding the complexities of clinical and genetic diagnosis, natural history, and management of hypertrophic cardiomyopathy (HCM)—the most common and important of the genetic cardiovascular diseases—as well as related issues impacting the health of trained athletes.    Edited by Dr. Barry J. Maron, a world authority on HCM, and with major contributions from all of the international experts in this field, this book provides a single comprehensive source of information concerning HCM. Recent advances in the field are discussed, including the importance of left ventricular outflow tract obstruction, the use of implantable defibrillators for the prevention of sudden death in young people, definition of the genetic basis for HCM and its role in clinical diagnosis and risk stratification, the development of more precise strategies for assessing the level of risk for sudden death among all patients with HCM, and the evolution of invasive interventions for heart failure symptoms, such as surgical management and its alternatives (alcohol septal ablation and dual-chamber pacing). Key Features: Contributions from all experts in the field, representing diverse viewpoints regarding this heterogeneous disease and related issues in athletes Information to dispel misunderstandings regarding issues associated with HCM and cardiovascular disease in athletes The only comprehensive source of information available on the topic